DK1181294T3 - Hidtil ukendte derivater og analoger af galanthamin - Google Patents
Hidtil ukendte derivater og analoger af galanthaminInfo
- Publication number
- DK1181294T3 DK1181294T3 DK01914813T DK01914813T DK1181294T3 DK 1181294 T3 DK1181294 T3 DK 1181294T3 DK 01914813 T DK01914813 T DK 01914813T DK 01914813 T DK01914813 T DK 01914813T DK 1181294 T3 DK1181294 T3 DK 1181294T3
- Authority
- DK
- Denmark
- Prior art keywords
- galanthamine
- analogs
- novel derivatives
- derivatives
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT5462000 | 2000-03-31 | ||
AT2382001 | 2001-02-15 | ||
PCT/AT2001/000082 WO2001074820A1 (de) | 2000-03-31 | 2001-03-22 | Neue derivate und analoga von galanthamin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1181294T3 true DK1181294T3 (da) | 2004-08-02 |
Family
ID=25608130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01914813T DK1181294T3 (da) | 2000-03-31 | 2001-03-22 | Hidtil ukendte derivater og analoger af galanthamin |
Country Status (26)
Country | Link |
---|---|
US (2) | US7166588B2 (da) |
EP (1) | EP1181294B1 (da) |
JP (1) | JP2003529602A (da) |
CN (1) | CN1380883A (da) |
AT (1) | ATE263171T1 (da) |
AU (1) | AU785385B2 (da) |
BG (1) | BG65134B1 (da) |
BR (1) | BR0105563A (da) |
CA (1) | CA2368966A1 (da) |
CZ (1) | CZ300160B6 (da) |
DE (1) | DE50101827D1 (da) |
DK (1) | DK1181294T3 (da) |
ES (1) | ES2215885T3 (da) |
HK (2) | HK1045990A1 (da) |
HU (1) | HUP0202233A3 (da) |
IS (1) | IS2287B (da) |
MX (1) | MXPA01012275A (da) |
NO (1) | NO326458B1 (da) |
NZ (1) | NZ516302A (da) |
PL (1) | PL202463B1 (da) |
PT (1) | PT1181294E (da) |
RU (1) | RU2241001C2 (da) |
SI (1) | SI1181294T1 (da) |
SK (1) | SK285909B6 (da) |
TR (1) | TR200400857T4 (da) |
WO (1) | WO2001074820A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
EP1681291A1 (de) * | 2002-03-25 | 2006-07-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Verfahren zur Herstellung von Norgalanthamin, Ihren Isomeren, Salzen und Hydraten |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
US7877350B2 (en) * | 2005-06-27 | 2011-01-25 | Ab Initio Technology Llc | Managing metadata for graph-based computations |
US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
ATE473219T1 (de) * | 2005-09-22 | 2010-07-15 | Galantos Pharma Gmbh | Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehen |
WO2008022365A2 (de) * | 2006-08-24 | 2008-02-28 | Sanochemia Ltd. | Mittel zum beeinflussen der wirkungen von organophosphorverbindungen und verwendung von galanthamin, dessen derivaten und analoga zum herstellen solcher mittel |
JP5504253B2 (ja) | 2008-04-14 | 2014-05-28 | ニューロダイン ライフ サイエンス インコーポレイテッド | ヒトの脳疾患の治療のためのプロドラッグとしてのガランタミン誘導体 |
BG110141A (en) * | 2008-05-23 | 2009-12-31 | "Софарма" Ад | GALANTAMINE DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE |
EP3287896B1 (en) | 2010-06-15 | 2023-04-26 | Ab Initio Technology LLC | Dynamically loading graph-based computations |
WO2013160728A1 (en) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Dual targeting compounds for the treatment of alzheimer's disease |
US10108521B2 (en) * | 2012-11-16 | 2018-10-23 | Ab Initio Technology Llc | Dynamic component performance monitoring |
CA3128713C (en) | 2013-12-05 | 2022-06-21 | Ab Initio Technology Llc | Managing interfaces for dataflow graphs composed of sub-graphs |
JP6479966B2 (ja) | 2014-09-02 | 2019-03-06 | アビニシオ テクノロジー エルエルシー | ユーザインタラクションを通じたグラフに基づくプログラム内の構成要素のサブセットの視覚的な規定 |
JP6467497B2 (ja) | 2014-09-02 | 2019-02-13 | アビニシオ テクノロジー エルエルシー | 特定のデータポートの接続の特定に基づいてグラフの構成要素の自動化されたクラスタリングによるグラフに基づくプログラムの仕様のコンパイル |
US10657134B2 (en) | 2015-08-05 | 2020-05-19 | Ab Initio Technology Llc | Selecting queries for execution on a stream of real-time data |
US12006301B1 (en) | 2021-05-13 | 2024-06-11 | Florida A&M University | And synthesis of dual 5-HT1A and 5-HT7 receptor ligands |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947445A (en) * | 1974-05-09 | 1976-03-30 | Stanford Research Institute | Diazabicyclooctanes and diazabicycloheptanes |
US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
KR100195399B1 (ko) * | 1987-05-04 | 1999-06-15 | 보니데이비스 | 알쯔하이머 병 치료용 의약 |
NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
US4954502A (en) | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US5153193A (en) * | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
US6323195B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323196B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US5428159A (en) | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
US6407229B1 (en) | 1994-10-21 | 2002-06-18 | Sanochemia Pharmazeutika Ag | Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine |
AT401058B (de) | 1994-10-21 | 1996-06-25 | Waldheim Pharmazeutika Gmbh | Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins |
NZ294191A (en) * | 1994-10-21 | 1998-10-28 | Waldheim Pharmazeutika Gmbh | Process for preparing 4a,5,9,10,11,12-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine derivatives and intermediates thereof |
GB9514821D0 (en) * | 1995-07-19 | 1995-09-20 | Sod Conseils Rech Applic | Galanthamine derivatives |
GB9519268D0 (en) | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
GB9716879D0 (en) * | 1997-08-08 | 1997-10-15 | Shire Int Licensing Bv | Treatment of attention deficit disorders |
AU1430099A (en) * | 1998-12-01 | 2000-06-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage |
AT414125B (de) | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
-
2001
- 2001-03-22 CA CA002368966A patent/CA2368966A1/en not_active Abandoned
- 2001-03-22 SI SI200130081T patent/SI1181294T1/xx unknown
- 2001-03-22 DE DE50101827T patent/DE50101827D1/de not_active Expired - Lifetime
- 2001-03-22 PL PL352638A patent/PL202463B1/pl not_active IP Right Cessation
- 2001-03-22 DK DK01914813T patent/DK1181294T3/da active
- 2001-03-22 JP JP2001572510A patent/JP2003529602A/ja active Pending
- 2001-03-22 ES ES01914813T patent/ES2215885T3/es not_active Expired - Lifetime
- 2001-03-22 NZ NZ516302A patent/NZ516302A/xx unknown
- 2001-03-22 RU RU2001135839/04A patent/RU2241001C2/ru not_active IP Right Cessation
- 2001-03-22 AU AU42085/01A patent/AU785385B2/en not_active Ceased
- 2001-03-22 CZ CZ20014178A patent/CZ300160B6/cs not_active IP Right Cessation
- 2001-03-22 HU HU0202233A patent/HUP0202233A3/hu unknown
- 2001-03-22 EP EP01914813A patent/EP1181294B1/de not_active Expired - Lifetime
- 2001-03-22 PT PT01914813T patent/PT1181294E/pt unknown
- 2001-03-22 WO PCT/AT2001/000082 patent/WO2001074820A1/de active IP Right Grant
- 2001-03-22 TR TR2004/00857T patent/TR200400857T4/xx unknown
- 2001-03-22 MX MXPA01012275A patent/MXPA01012275A/es active IP Right Grant
- 2001-03-22 AT AT01914813T patent/ATE263171T1/de not_active IP Right Cessation
- 2001-03-22 SK SK1702-2001A patent/SK285909B6/sk not_active IP Right Cessation
- 2001-03-22 CN CN01801342A patent/CN1380883A/zh active Pending
- 2001-03-22 BR BR0105563-1A patent/BR0105563A/pt not_active IP Right Cessation
- 2001-05-22 US US09/980,025 patent/US7166588B2/en not_active Expired - Fee Related
- 2001-11-23 IS IS6174A patent/IS2287B/is unknown
- 2001-11-28 BG BG106155A patent/BG65134B1/bg unknown
- 2001-11-30 NO NO20015857A patent/NO326458B1/no not_active IP Right Cessation
-
2002
- 2002-08-23 HK HK02106231A patent/HK1045990A1/xx not_active IP Right Cessation
-
2003
- 2003-03-14 HK HK03101873.7A patent/HK1049832A1/zh unknown
-
2006
- 2006-06-28 US US11/478,170 patent/US20070027138A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0000540D0 (sv) | New compounds | |
DK1181294T3 (da) | Hidtil ukendte derivater og analoger af galanthamin | |
CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
ATE491703T1 (de) | Phthalazinonderivate | |
CY1111648T1 (el) | Πολυαρυλκαρβοξαμιδια χρησιμα ως παραγοντες μειωσης λιπιδιων | |
ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
TW200510368A (en) | Pharmaceutical compositions and combinations of novel non-imidazole compounds | |
DK1438306T3 (da) | Derivater af UK-2A | |
NO20042534L (no) | Forbedringer vedrorende optiske lysgjoringsmidler | |
CY1113657T1 (el) | Νεα παραγωγα βενζοφαινονης ή αλατα αυτων | |
ECSP056130A (es) | Compuestos farmacéuticos novedosos | |
CY1106534T1 (el) | Αρωματικες εξαμελεις κυκλικες ενωσεις που περιεχουν αζωτο | |
UY28625A1 (es) | Nuevos compuestos farmacéuticos | |
YU25497A (sh) | Postupak za dobijanje sildenafila | |
CY1110104T1 (el) | Παραγωγα της πιπεραζινης ως αναστολεις ταχυκινινων | |
CY1105385T1 (el) | Παραγωγα αλφα-αμινο-οξεων, μεθοδος για την παρασκευη αυτων και χρηση αυτων σαν αναστολεις διπεπτιδυλ-πεπτιδασης iv (dpp iv) | |
UY26899A1 (es) | Derivados de pirazol fusionados | |
BR0213981A (pt) | Fotoiniciadores difuncionais | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
CY1105411T1 (el) | Νεα παραγωγα πλευρομουτιλινης | |
CO5580821A2 (es) | 4-cetolactamas y -lactonas 3-fenil-3-substituidas, espirociclicas | |
DE60121587D1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
BRPI0416678A (pt) | pirazolpirimidinas |